From a small beginning that was initiated way back with the post acquisition of majority shareholding of Dabur Pharma by Fresenius Kabi, the Company has indeed come a long way and established itself as a leading player in the field of oncology generics. Fresenius Kabi Oncology Limited has innovated and developed many life-saving products for cancer patients. We are a company with rich and diverse corporate heritage and with this prophecy we have strived and continued to provide unmatched facilities for R&D and manufacturing in the diverse field of Oncology Generics and its intricate field of research.